Expert Interview
A second look: Discussing current commercial uptake of Verona's OHTUVAYRE (ensifentrine) in COPD
Ticker(s): VRNAInstitution: Loyola University Chicago
- Associate Clinical Professor of Medicine at Loyola University Chicago, Pulmonology
- Provides care to patients with a variety of diseases including chronic obstructive pulmonary disease (COPD), pulmonary hypertension, asthma, interstitial lung disease, lung cancer, sepsis, and acute respiratory distress syndrome (ARDS).
- Clinical and research interests are in quality improvement process management, COPD, asthma, refractory chronic cough, lung cancer, and advanced bronchoscopic modalities. He has experience as a national educational proctor for robotic bronchoscopy.
how many times have you prescribed ensifentrine?
Added By: wilson_adminin which patients are you prescribing ensifentrine?
Added By: wilson_admindo you see your use of ensifentrine increasing over time?
Added By: wilson_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
